Online citations, reference lists, and bibliographies.
← Back to Search

Nanomaterials And Their Applications In Bioimaging

R. Rani, K. Sethi, G. Singh
Published 2019 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanomaterials have shown great potential in bioimaging, drug delivery, and targeted cancer therapies owing to their physicochemical properties and good biocompatibility. Among various clinical areas, bioimaging techniques based on nanomaterials have advanced very quickly with the development of nanoparticles with different functionalizations.
This paper references
10.22377/AJP.V11I01.1083
Applications of Nanoparticles in Magnetic Resonance Imaging: A Comprehensive Review
Halime Mansoury Asl (2017)
10.3390/ijms151223616
Contrast Agents for Photoacoustic and Thermoacoustic Imaging: A Review
D. Wu (2014)
10.1016/j.biomaterials.2016.06.015
Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.
R. Cheheltani (2016)
10.1016/j.jconrel.2015.11.016
The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Yongwei Hao (2015)
10.1021/AR600032U
Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release.
B. Trewyn (2007)
10.1126/science.1125949
Molecular Imaging in Cancer
R. Weissleder (2006)
10.1002/anie.200701674
Chemical design of nanoparticle probes for high-performance magnetic resonance imaging.
Y. Jun (2008)
10.2217/nnm.14.171
Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.
Lisa E. Cole (2015)
10.1039/b711069c
Chemical sensing and imaging with metallic nanorods.
C. Murphy (2008)
10.1021/cr2001178
Gold nanoparticles in chemical and biological sensing.
K. Saha (2012)
10.1038/NMAT1849
The rise of graphene.
Andre K. Geim (2007)
10.1021/AR9602664
Monolayer-protected cluster molecules.
A. C. Templeton (2000)
10.1016/j.biomaterials.2016.02.009
Labeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography.
P. Chhour (2016)
10.1155/2018/5837276
Gold Nanoparticles as X-Ray, CT, and Multimodal Imaging Contrast Agents: Formulation, Targeting, and Methodology
Matthew M. Mahan (2018)
10.1021/BC060035+
Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas.
X. Montet (2006)
10.1039/b812302k
Gd3+-functionalized near-infrared quantum dots for in vivo dual modal (fluorescence/magnetic resonance) imaging.
T. Jin (2008)
10.1021/ja071471p
Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
D. Kim (2007)
10.1021/NL8029114
Targeted gold nanoparticles enable molecular CT imaging of cancer.
R. Popovtzer (2008)
10.1259/BJR/13169882
Gold nanoparticles: a new X-ray contrast agent.
J. Hainfeld (2006)
10.1021/nn2023123
Biofunctional quantum dots: controlled conjugation for multiplexed biosensors.
N. Hildebrandt (2011)
10.1021/bc8002698
Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging.
X. Gao (2008)
10.1109/58.981381
Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model
J. Marsh (2002)
10.1007/s00415-012-6428-3
Positron emission tomography imaging in neurological disorders
M. Politis (2012)
10.1016/j.arr.2016.02.003
Brain fluorodeoxyglucose (FDG) PET in dementia
Takashi Kato (2016)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.1097/00004424-199405001-00009
Synthesis of water-soluble ionic and nonionic iodinated x-ray contrast media.
P. Blaszkiewicz (1994)
10.1016/B978-0-323-50878-0.00009-4
Graphene-Based Nanomaterials in Bioimaging
Jing Lin (2018)
10.1016/S1052-5149(03)00108-4
Positron emission tomography imaging of the aging brain.
C. Meltzer (2003)
10.1021/NL0482478
Bright and stable core-shell fluorescent silica nanoparticles.
Hooisweng Ow (2005)
10.1007/s00117-006-1447-7
Molekulare Bildgebung – ein neuer Schwerpunkt der Radiologie
R. Weissleder (2006)
10.2147/IJN.S59754
Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging
Sihan Xue (2014)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1038/347354a0
Solid C60: a new form of carbon
W. Kraetschmer (1990)
10.1016/j.mex.2016.04.003
Nanometric resolution magnetic resonance imaging methods for mapping functional activity in neuronal networks
Albert Boretti (2016)
10.1039/c3cs60273g
Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy.
V. Biju (2014)
10.1039/c2an35863h
Tracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation.
Carlos Pérez-Campaña (2012)
種結晶を媒介とした成長法を用いた金ナノロッド(NR)の調製と成長メカニズム
B. Nikoobakht (2003)
10.1039/c2cc33543c
pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.
P. Shi (2012)
10.1021/cr300068p
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.
L. H. Reddy (2012)
10.1021/JA003633M
Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor.
Z. Peng (2001)
10.1002/SMLL.200600427
Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies.
Vijaya Kattumuri (2007)
10.1016/j.dld.2013.02.009
¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography for the evaluation of bone metastasis in patients with gastric cancer.
D. W. Ma (2013)
10.1111/j.1349-7006.2011.02056.x
Evaluation of antitumor effects following tumor necrosis factor‐α gene delivery using nanobubbles and ultrasound
S. Horie (2011)
10.1080/10408430903505036
Synthesis of Graphene and Its Applications: A Review
Wonbong Choi (2010)
10.1073/pnas.152463399
Nanocrystal targeting in vivo
M. Akerman (2002)
10.1039/c7nr01153a
Evaluation of spectral photon counting computed tomography K-edge imaging for determination of gold nanoparticle biodistribution in vivo.
S. Si-Mohamed (2017)
10.1016/j.biomaterials.2009.06.038
Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications.
Hagit Aviv (2009)
10.1111/1756-185X.12316
Positron emission tomography/computed tomography imaging and rheumatoid arthritis
Shicun Wang (2014)
10.1259/bjr/97295129
Positron emission tomography imaging in dementia.
K. Herholz (2007)
10.1007/s40089-015-0176-1
Synthesis of graphene
M. S. Bhuyan (2016)
10.3390/nano6050081
Dye-Doped Fluorescent Silica Nanoparticles for Live Cell and In Vivo Bioimaging
Wenhan Zhang (2016)
10.1016/J.REMNIE.2016.06.006
Simultaneous PET/MRI vs PET/CT in oncology. A systematic review.
C. Riola-Parada (2016)
10.1088/0031-9155/49/18/N03
The use of gold nanoparticles to enhance radiotherapy in mice.
J. Hainfeld (2004)
10.1038/nnano.2009.231
Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents.
J. Kim (2009)
10.1039/C39940000801
Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system
M. Brust (1994)
10.1016/j.aca.2013.05.056
Size characterization by Sedimentation Field Flow Fractionation of silica particles used as food additives.
C. Contado (2013)
10.1371/journal.pone.0000907
PET Imaging of Soluble Yttrium-86-Labeled Carbon Nanotubes in Mice
M. McDevitt (2007)
10.1002/ADMA.200702770
Dendrimer‐Functionalized Shell‐crosslinked Iron Oxide Nanoparticles for In‐Vivo Magnetic Resonance Imaging of Tumors
X. Shi (2008)
10.1038/nnano.2009.241
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics.
K. Kostarelos (2009)
10.2147/IJN.S13300
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
A. Ruggiero (2010)
10.1155/2012/631584
Bifunctional silica-coated superparamagnetic FePt nanoparticles for fluorescence/MR dual imaging
Syu-Ming Lai (2012)
10.2217/NNM.15.77
Tetronic® 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS.
M. I. Roma (2015)
10.1371/journal.pone.0185926
Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery
L. Mosconi (2017)
10.1016/j.biomaterials.2014.04.005
Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer.
Lijia Jing (2014)
10.1177/030089160809400215
MR and Iron Magnetic Nanoparticles. Imaging Opportunities in Preclinical and Translational Research
C. Neumaier (2008)
10.1021/BC034153Y
Noninvasive imaging of quantum dots in mice.
B. Ballou (2004)
10.1016/j.msec.2014.07.055
Enhanced contrast efficiency in MRI by PEGylated magnetoliposomes loaded with PEGylated SPION: effect of SPION coating and micro-environment.
A. Carvalho (2014)
10.1039/c6cs00517a
Carbon nanotubes: a novel material for multifaceted applications in human healthcare.
S. Kumar (2017)
10.4103/2347-8659.143659
Positron emission tomography imaging in gliomas
A. Assimakopoulos (2014)
10.1016/j.nano.2013.06.008
New long circulating magnetoliposomes as contrast agents for detection of ischemia-reperfusion injuries by MRI.
M. Martins (2014)
10.1021/ja3016582
Multifunctional Fe3O4/TaO(x) core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography.
N. Lee (2012)
10.3390/ijms17081209
Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T2 Contrast Agents for MRI
R. Martínez-González (2016)
10.2147/IJN.S5964
Biomedical applications of functionalized fullerene-based nanomaterials
Ranga Partha (2009)
10.1039/c4cs00476k
Nanomaterial-based activatable imaging probes: from design to biological applications.
J. Li (2015)
10.1002/mrm.10068
Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model
P. Wunderbaldinger (2002)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1021/JA00072A025
Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites
C. Murray (1993)
10.1021/NL052405T
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
W. Cai (2006)
10.1177/1178623X17722134
Development of New Contrast Agents for Imaging Function and Metabolism by Magnetic Resonance Imaging
A. Carvalho (2017)
10.1097/RLI.0b013e31811ecdcd
Colloidal Gold Nanoparticles as a Blood-Pool Contrast Agent for X-ray Computed Tomography in Mice
Quan-Yu Cai (2007)
10.1016/B978-0-323-46142-9.00018-9
Quantum dots for bioimaging and therapeutic applications
G. Vlăsceanu (2017)
10.1039/c1cs15237h
The golden age: gold nanoparticles for biomedicine.
Erik C Dreaden (2012)
10.1038/nm1467
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
10.1038/nnano.2008.231
Carbon nanotubes as photoacoustic molecular imaging agents in living mice.
A. de la Zerda (2008)
10.1021/CR980441P
Metal-Based X-ray Contrast Media.
S. Yu. (1999)
10.1021/ja1035013
In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging.
S. Chou (2010)
10.1007/s11095-010-0276-6
An Effective Strategy for the Synthesis of Biocompatible Gold Nanoparticles Using Cinnamon Phytochemicals for Phantom CT Imaging and Photoacoustic Detection of Cancerous Cells
Neelatphal Chanda (2010)
10.2147/IJN.S152461
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
M. Shevtsov (2018)
10.1002/cmmi.1551
Nanoparticle contrast agents for computed tomography: a focus on micelles.
D. Cormode (2014)
10.1002/cmmi.1539
Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
Linda Karmani (2013)
10.1016/S1076-6332(03)80206-4
Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent.
S. Wickline (2002)
10.1016/S1076-6332(03)80210-6
Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents.
P. Wunderbaldinger (2002)
10.3390/nano6040076
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging
Kondareddy Cherukula (2016)
10.1148/RADIOLOGY.145.3.7146409
Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
R. Mattrey (1982)
10.1016/j.biomaterials.2016.06.058
Functional long circulating single walled carbon nanotubes for fluorescent/photoacoustic imaging-guided enhanced phototherapy.
L. Xie (2016)
10.2967/jnumed.115.163717
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
T. Grimmer (2016)
10.1021/JA052337C
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals.
Y. Huh (2005)
10.1021/acsami.5b12400
Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy.
G. Wang (2016)
10.1002/cmmi.376
A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging.
Matti M. van Schooneveld (2010)
10.1016/j.actbio.2017.01.078
Single wavelength light-mediated, synergistic bimodal cancer photoablation and amplified photothermal performance by graphene/gold nanostar/photosensitizer theranostics.
Chunhui Wu (2017)
10.1021/nn1024303
In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice.
K. Yang (2011)
10.1016/j.crad.2017.09.001
PET/CT and PET/MRI in head and neck malignancy.
T. Szyszko (2018)
10.1021/CM020732L
Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method
Babak Nikoobakht and (2003)
10.1039/C7TB01425B
Application of semiconductor quantum dots in bioimaging and biosensing.
I. V. Martynenko (2017)
10.1016/j.ijpharm.2010.06.005
In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts.
H. Xie (2010)
10.3390/ijms140815910
Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
R. Thomas (2013)
10.1148/radiol.10092473
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.
D. Cormode (2010)
10.3390/nano6040066
Automatic Echographic Detection of Halloysite Clay Nanotubes in a Low Concentration Range
F. Conversano (2016)
10.1039/c3cs35405a
Synthesis of mesoporous silica nanoparticles.
Si-Han Wu (2013)
10.1016/B978-012374212-4.50079-1
Molecular Imaging of Cancer with Superparamagnetic Iron-Oxide Nanoparticles
D. Thorek (2008)
10.2147/IJN.S75174
Water-soluble l-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma
Shuyan Liang (2015)
10.1021/J100082A044
CdS Nanoclusters: Synthesis, Characterization, Size Dependent Oscillator Strength, Temperature Shift of the Excitonic Transition Energy, and Reversible Absorbance Shift
T. Vossmeyer (1994)
10.1007/s00395-008-0711-6
Contrast agents for MRI
E. A. Waters (2008)
10.1016/j.biomaterials.2016.10.030
Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.
Shi Gao (2017)
10.1097/00004424-199510000-00006
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
E. Schulze (1995)
10.1007/978-3-030-16439-3_11
Magnetic Nanostructures: Environmental and Agricultural Applications
T. S. Bhalerao (2019)
10.1016/j.biomaterials.2011.05.019
Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging.
Z. Liu (2011)
10.1088/0957-4484/20/1/015102
Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging.
K. Yong (2009)
10.1021/nn300392x
An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging.
D. Pan (2012)
10.1146/ANNUREV.BIOENG.8.061505.095831
Fluorescence molecular imaging.
V. Ntziachristos (2006)
10.2174/1568026611212230007
Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
P. Bouziotis (2012)
10.7150/thno.7341
Radiolabeled Nanoparticles for Multimodality Tumor Imaging
Y. Xing (2014)
10.1016/J.JMMM.2009.11.039
One-pot synthesis of amphiphilic superparamagnetic FePt nanoparticles and magnetic resonance imaging in vitro
H. Yang (2010)
10.1161/01.CIR.94.12.3334
A novel site-targeted ultrasonic contrast agent with broad biomedical application.
G. Lanza (1996)
10.1097/RLU.0000000000000359
PET in Multiple Sclerosis
F. Niccolini (2015)
10.1158/0008-5472.CAN-06-1185
In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.
H. Tada (2007)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.1016/j.dld.2014.03.011
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
S. Crippa (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar